Integrated Multi-Omics Cell Cycle Modeling & Risk Stratification Service
Creative Biolabs provides a decisive edge in precision oncology by transforming multi-modal data into high-fidelity prognostic models. We address development failures by identifying redundant regulatory loops and compensatory pathways inherent in cell cycle dysregulation, enabling the discovery of synergistic drug targets. By resolving "molecular noise," our platform generates statistically validated signatures correlating with overall survival and progression-free survival for precise cohort stratification. This level of insight optimizes lead selection and minimizes downstream risks by grounding discovery in robust, clinically relevant risk profiles.
Background What We Can Offer Workflow Publication Why Choose Us FAQs Customer Review Related Services Contact Us
Introduction to Multi-Omics Cell Cycle Modeling
The cell cycle serves as a master regulator of biological fate, where dysregulation cascades through the epigenome, transcriptome, and metabolome. Current scientific consensus confirms that integrated modeling, incorporating miRNA-mRNA-TF axes, m6A methylation, and metabolic reprogramming, provides a prognostic framework far superior to traditional, single-layer methods. Creative Biolabs utilizes these multidimensional insights to help you navigate the complexities of genomic instability and immune evasion. Our holistic approach ensures your research accounts for the interconnected pathways that drive disease progression and therapeutic resistance.
Comprehensive Solutions and Deliverables
Our service is built to provide actionable outputs that can be directly integrated into your pipeline. We don't just provide data; we provide a biological roadmap.
Mechanistic Risk Scoring
We utilize LASSO-Cox regression and random survival forests (RSF) to generate a "cell cycle risk score." This score effectively partitions biological samples into high- and low-risk groups with time-dependent area under the curves (AUCs) frequently exceeding 0.90, providing a reliable metric for experimental decision-making.
Regulatory Network Mapping
We provide high-resolution maps of miRNA-mRNA-transcription factor (TF) axes. This includes identifying central hub genes such as CCNB1, TOP2A, and KIF11, which are often the primary drivers of genomic instability.
Immunogenic Footprinting
We deliver detailed analyses of how cell cycle risk scores correlate with the tumor microenvironment (TME). This includes quantifying the infiltration of immunosuppressive cell types, such as SPP1+/SLC11A1+ macrophages, and predicting sensitivity to immune checkpoint modulators.
Unlock the Potential of Your Research Data — Request an Expert Consultation Today
Precision Service Workflow
Our workflow is designed to bridge the gap between complex biological samples and research decision-making by utilizing standardized pipelines for data harmonization, advanced machine learning for feature selection, and robust validation against global genomic repositories.
Publication
This study establishes a novel prognostic signature based on centrosome amplification-related genes in pancreatic adenocarcinoma. By integrating multi-omics data, five key genes (IFI27, KIF20A, KLK10, SPINK7, TOP2A) were identified as potent diagnostic and prognostic biomarkers. The robust model correlates with aggressive tumor behavior, chemoresistance, and an immunosuppressive microenvironment, providing a valuable framework for patient risk stratification and guiding targeted therapy.
Fig.1 Transcriptomic profiling identifies potential biomarkers in pancreatic cancer.1
Why Choose Us?
Creative Biolabs offers an unparalleled depth of expertise in systems biology. Unlike standard providers, we integrate "dark matter" omics, such as non-coding RNA regulation and epigenetic stability, to ensure no regulatory node is overlooked. Our models are grounded in published data showing superior performance in predicting chemoresistance and immune evasion compared to traditional transcriptomic panels. By choosing Creative Biolabs, you gain access to a multidisciplinary team of Ph.D. scientists who specialize in converting complex biological noise into clear therapeutic strategies. Our proprietary pipelines for batch-effect correction and deep-learning data fusion ensure that the insights you receive are both robust and reproducible.
Experience the Creative Biolabs Advantage - Get a Personalized Quote for Your Project Today
FAQs
How does Creative Biolabs ensure the accuracy of the risk scores?
We employ a "double-validation" strategy, using both internal cross-validation and external validation against massive public repositories like TCGA. This ensures that the cell cycle signature is robust across different research cohorts.
Can you integrate data from different sequencing platforms?
Yes. Our bioinformatic pipeline is specifically designed for cross-platform integration, using advanced normalization techniques to eliminate platform-specific biases.
How are metabolic enzymes like ENO1 linked to cell cycle risk?
Cycling cells have unique biosynthetic demands. Our models identify "metabolic checkpoints" where cell cycle drivers upregulate glycolytic or lipid pathways, offering new windows for therapeutic intervention.
Customer Review
-
Exceptional Predictive Accuracy
The risk score derived by Creative Biolabs outperformed every single-gene biomarker we had tested previously. Their integration of metabolic enzymes like ENO1 into the cell cycle model was a game-changer for our metabolism-focused program. - Prof. Ma** v
-
Seamless Data Integration
We provided raw data from three different platforms, and the team at Creative Biolabs delivered a unified, high-fidelity model that was publication-ready. Their attention to batch-effect correction and validation was top-tier. - Dr. Ke***n W
Related Services
Epigenetic & microRNA Regulation Analysis
Creative Biolabs decodes the "Epi-miRNA" axis to identify pharmacologically unmaskable targets. We map how epigenetic silencing drives cell cycle dysregulation, ensuring candidates are grounded in functional regulatory logic.
Learn More →
Gut Microbiota Single-cell Transcriptional Profiling
Creative Biolabs provides gut microbiota single-cell transcriptional profiling to reconstruct functional units. We resolve immune cell complexity and fate trajectories, transforming tissue-specific clues into mechanistic insights.
Learn More →
How to Contact Creative Biolabs
Creative Biolabs provides a market-leading service that bridges the gap between complex biological data and successful research outcomes. By integrating genomic, regulatory, and metabolic layers, we offer a comprehensive solution for target discovery and sample stratification.
Ready to elevate your research program? Contact our team of Ph.D. scientists today to discuss a customized multi-omics cell cycle modeling strategy for your lead candidates.
Reference
-
Sun, Yuan, et al. "Development and Validation of a Centrosome Amplification-Related Prognostic Model in Pancreatic Cancer: Multi-Omics Guided Risk Stratification and Tumor Microenvironment." Cancers 17.18 (2025): 2983. Distributed under Open Access license CC BY 4.0, without modification. https://doi.org/10.3390/cancers17182983
For Research Use Only | Not For Clinical Use
Download our brochure